BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6849741)

  • 1. Cardiovascular effects of indoramin in man--a dose ranging study.
    Nicholls DP; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1983 Jan; 15(1):31-6. PubMed ID: 6849741
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular effects of intravenous indoramin hydrochloride in man.
    Coleman AJ; Leary WP; Asmal AC
    J Int Med Res; 1979; 7(6):511-8. PubMed ID: 520654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical pharmacology of indoramin.
    Shanks RG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S8-15. PubMed ID: 2423804
    [No Abstract]   [Full Text] [Related]  

  • 4. On the mechanisms of hypotensive action of indoramin.
    Gulati K; Srimal RC; Dhawan BN
    Pol J Pharmacol Pharm; 1978; 30(6):811-8. PubMed ID: 755245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure.
    De Kock MR; Detry JM
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S107-11. PubMed ID: 2423782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.
    Pierce V; Shepperson NB; Todd MH; Waterfall JF
    Br J Pharmacol; 1986 Feb; 87(2):433-41. PubMed ID: 3955309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
    Nicholls DP; McNeill J; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiovascular effects of centrally and peripherally administered indoramin in conscious rats.
    Porter JP; Bonham AC; Mangiapane ML; Webb RL; Brody MJ
    Eur J Pharmacol; 1985 Feb; 109(1):9-17. PubMed ID: 3996469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients.
    Velasco M; Urbina-Quintana A; Andrews-Figueroa P; Nieves D; Hernández E; Guevara-Casado J; Hernández-Pieretti O
    Clin Pharmacol Ther; 1982 Jul; 32(1):7-11. PubMed ID: 7083732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of indoramin on finger blood flow in vasospastic patients.
    Clement DL
    Eur J Clin Pharmacol; 1978 Dec; 14(5):331-3. PubMed ID: 729626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential blockade of alpha-adrenoceptors by indoramin.
    Nicholls DP; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Jun; 17(6):719-28. PubMed ID: 6146328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute and chronic effects of indoramin on renal function, hemodynamics, and transport.
    Morrison G; Spar B; Walker BR; Goldfarb S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S25-9. PubMed ID: 2423792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs.
    Harron DW; Kerr MJ; Shanks RG
    J Cardiovasc Pharmacol; 1984; 6(4):596-600. PubMed ID: 6206312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Alpha-adrenoceptor inhibition from indoramin in man.
    Boakes AJ; Prichard BN; Teoh PC
    Br J Pharmacol; 1972 Feb; 44(2):378P-379P. PubMed ID: 4148923
    [No Abstract]   [Full Text] [Related]  

  • 15. Indoramin as an antihypertensive agent in the treatment of essential hypertension. A multicentre trial.
    Bednarek MR; Schoeman HS
    S Afr Med J; 1983 Mar; 63(11):398-400. PubMed ID: 6338603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral contribution to the antihypertensive action of indoramin.
    Baum T; Shropshire AT
    Eur J Pharmacol; 1975 May; 32(1):30-8. PubMed ID: 168091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the renal effects of indoramin and prazosin.
    Strandhoy JW
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S151-5. PubMed ID: 2423789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indoramin, a drug with prevalent antihypertensive activity: experimental study].
    Marmo E; Rossi F; Caputi AP; Lampa E; Petrarca R; Ottavo R
    Clin Ter; 1979 Feb; 88(3):233-62. PubMed ID: 445975
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for a central sympathoinhibitory action of prazosin and indoramin.
    Ramage AG
    Eur J Pharmacol; 1986 Feb; 121(1):83-9. PubMed ID: 3956575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
    Holmes B; Sorkin EM
    Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.